BSEResult2d ago · 13 Oct 2026, 01:30 pm

Financial results for quarter and half year ended September 30, 2026.

ICICI Prudential Life Insurance Company Ltd · 540133

✦ AI SummaryResults

ICICI Prudential Life Insurance Company Ltd has announced its financial results for the quarter and half year ended September 30, 2026, with gross premium income of ₹1,380.39 crore and net premium income of ₹2,355.32 crore. The company has also announced the appointment of Mr. Sidharatha Mishra as an Additional Director, effective October 14, 2026.

Analysis Scores

Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

ICICI Prudential Life Insurance Company Ltd - 540133 - Outcome Of The Board Meeting Held On October 13, 2026

Attachments (1)

📄

f4e49dc8-a052-497a-b609-479298c5b96d.pdf

pdf

Download →
View document text
October 13, 2026 Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers ‘Exchange Plaza’ Dalal Street, Bandra-Kurla Complex Mumbai 400 001 Bandra (East), Mumbai 400 051 Dear Sir/Madam, Scrip Code: Equity (BSE: 540133/NSE: ICICIPRULI) Debt (NSE: ICPR34, ICPR35) Subject: Outcome of the Board Meeting held on October 13, 2026 The Board of Directors (the Board) of ICICI Life Insurance Limited at their meeting, which commenced at 11:05 a.m. and concluded at 1:07 p.m. on Tuesday, October 13, 2026, inter alia, approved the Un-audited financial statements and financial results (standalone) for the quarter and half year ended September 30, 2026. Pursuant to Regulation 33, Regulation 52 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a copy of the un-audited financial results (standalone) for the quarter and half year ended September 30, 2026, the limited review reports issued by M. P. Chitale & Co. and Chaturvedi & Co LLP, the joint statutory auditors in the prescribed format, along with a copy of press release are enclosed. Further, as per the Regulation 23(9) of the Listing Regulations, the listed entity shall submit to the stock exchanges, the disclosures of related party transactions in the prescribed format. Please be informed that said disclosures shall also be filed in prescribed XBRL format, as a part of Integrated Filing (Financial) simultaneously. In continuation to the intimation dated October 2, 2026, upon appointment as an Additional Director effective October 14, 2026, Mr. Sidharatha Mishra shall cease to be a Senior Management Personnel, from the said date. The disclosures as per Regulation 30 and 51 alongwith the details as required under Para A (7) of Part A of Schedule III of Listing Regulations read with SEBI Master Circular dated January 30, 2026 are enclosed herewith as Annexure I. Kindly take the above information on records. Thanking you, Yours sincerely, For ICICI Life Insurance Limited (Formerly known as ICICI Prudential Life Insurance Company Limited) Priya Nair Company Secretary ACS 17769 Encl.: As above CC: Axis Trustee Services Limited, Debenture Trustee ICICI Life Insurance Limited (Formerly known as: ICICI Prudential Life Insurance Company Limited) Regd. Office: ICICI Prulife Towers, 1089, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, India. Phone: +91 22 4039 1600 | Email: corporate@icicilife.com | Visit us at www.icicilife.com | CIN: L66010MH2000PLC127837 Annexure I Sr. Particulars Descri ption 1. Reasons for change viz. appointment, Upon appointment as an Additional Director re-appointment, resignation, removal, effective October 14, 2026, Mr. Sidharatha death or otherwise Mishra shall cease to be a Senior Management Personnel, from the said date. 2. Date of appointment/re- Please refer Point no. 1 above. appointment/cessation (as applicable) and term of appointment/re- appointment 3. Brief Profile (in case of appointment) Not applicable 4. Disclosure of relationships between Not applicable Directors (in case of appointment of a director) ICICI Life Insurance Limited (Formerly known as: ICICI Prudential Life Insurance Company Limited) Regd. Office: ICICI Prulife Towers, 1089, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, India. Phone: +91 22 4039 1600 | Email: corporate@icicilife.com | Visit us at www.icicilife.com | CIN: L66010MH2000PLC127837 ICICI Life Insurance Limited (Formerly known as ICICI Prudential Life Insurance Company Limited) Statement of Standalone Unaudited Results for the quarter and half year ended September 30, 2026 (fin Lakhs) Three months ended/at Six months ended/at Year ended/at Sr Particulars September 30, June 30, September 30, September 30, September 30, March 31, No. 2026 2026 2025 2026 2025 2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) {Audited) POLICYHOLDERS' ACCOUNT Gross premium income 1 (o) First Year Premium 214,570 171,186 197,517 385,756 342,059 843,223 (b} Renewal Premium 729,647 538,360 685,178 1.268,007 1,179,343 2,831,556 le) Single Premium 481.242 315,517 347,008 796,759 603,705 1,637,685 2 Net oremium income1 1,380,390 974,933 1.184,310 2,355,323 2,034,629 5,133,563 3 Income from investments: lNetl 2 1212,329) 1.850,024 (22,667) 1,637,695 1,642,192 1,086,515 4 Other income 6,625 9,360 5,792 15,985 11,034 22,987 5 Transfer of funds from Shareholders' A/c (421) 5,173 34,129 4,752 45,724 98,973 6 Total (2 to 5) 1,174,265 2,839,490 1,201,564 4,013,755 3,733,579 6,342,038 Commission on 7 {a) First Year Premium 51,886 30,423 47,562 82,309 80,443 210,985 (b) Renewal Premium 14,736 10,364 15,189 25,100 25,984 60,097 {c) Singh:! Premium 70,933 60,629 57,625 131,562 108,384 247,025 8 Net Commission3 137,555 101,416 120,376 238,971 214,811 518,107 Operatinq Expenses related to insurance business 9 (a} Employees remuneration and welfare expenses 55,108 51,171 46,447 106,279 95,312 187,900 {b} Other operating expenses 72,754 70,161 48,361 142,915 94,170 254,711 10 Expenses of Management (8+9) 265,417 222,748 215,184 488,165 404,293 960,718 11 Provisions for doubtful debts (including bad debts written off) 570 641 2,041 1,211 2.489 5,821 12 Provisions for/(revcrsal of) diminution in value of investments (1,614) 13 Goods and Services tax on UUP chdrges 896 845 15,427 1,741 32,108 33,575 Provision for taxes {a+b) 1,045 3,845 4,682 4,890 9,358 125.296) 14 (a) Current tax (credit)/charge 1,045 3,845 4,682 4,890 9,358 (25,296) lb) Deferred tax (credit)/charge 15 Benefits Paid 4 (Net) 1 1,292,389 894,985 1,127,681 2,187,374 2,103,919 4,719,880 16 Change in actuarial liability (405,023) 1,668,814 (211,943) 1,263,791 1,095,296 402,744 17 Total (10+11+12+13+14+15+16) 1,155,294 2,791,878 1,153,072 3,947,172 3,647,463 6,095,828 18 Surplus/(Deficit) (6-17) 18,971 47,612 48,492 66,583 86,116 246,210 Appropriations 19 {a) Transferred to Shareholders 13,100 24,504 42,032 37,604 69,093 180,520 (b/ Funds for Future Appropriations 5,871 23,108 6,460 28,979 17,023 65,690 Details of Surplus/(Deficit) (a) Interim and other bonuses paid 22,098 19,937 21.305 42,035 37,541 98,670 (b) Allocation of bonus to policyholders - 67,659 (c) Surplus shown in the Revenue Account 18,971 47,612 48,492 66,583 86,116 246,210 Total Surplus 41,069 67,549 69,797 108,618 123,657 412,539 SHAREHOLDERS'ACCOUNT 21 Transfer from Policyholders' Account 13,100 24,504 42,032 37,604 69,093 180,520 Total income under Shareholders' Account 22 {a) Investment Income 35,073 26,314 31,833 61,387 56,674 126,588 (b) Other income 197 3,106 22 3,303 41 99 23 Expenses other than those related to insurance business 5,259 5,629 5,057 10,888 10.386 19,893 24 Transfer of funds to Policyholders A/c (421) 5,173 34,129 4,752 45,724 98,973 25 Provisions for doubtful debts {including write off) 28 26 Provisions for diminution in value of investments - - 513 7,638 27 Profit/(loss) before tax 43,532 43,122 34,701 86,654 69,185 180,675 Provisions for tax {a➔ b) 6,110 4,504 4,775 10,614 9,050 20,639 28 {a) Current tax (credit)/chorge 6,110 4,504 4,775 10,614 9,050 20,639 {b) Deferred tax (credlt)/chor9e - -·---· - 29 Profit/(loss) after tax and before extraordinary items 37,422 38,618 29,926 76,040 60,135 160,036 30 Extraordinary Items (Net of tax expenses) - - - 31 Profit/(loss) after tax and extraordinary items 37,422 38,618 29,926 76,040 60,135 160,036 Dividend per share (f) {Nominal Value f 10 per share}: 32 {a) Interim Dividend - (bl Final Dividend - - - - - 1.65 33 Profit/(Loss) carried to Balance Sheet 867,633 830,211 715,626 867,633 715,627 815,528 34 Paid up equity share capital 145,123 145,078 144,677 145,123 144,677 144,928 35 Reserve & Surplus {excluding Revaluation Reserve) 1,278,566 1,238,998 1,106,910 1,278,566 1,106,910 1,218,184 36 Fair value Change Account and revaluation reserve 39,639 53,422 21,138 39,639 21,138 (167) Total Assets: (a) Investments: -Shareholders' 1,644,753 1,6 [Showing first 8,000 characters — download PDF for full document]